(Q34422616)

2 August 2017

1 reference

title

Nucleic acid testing: update and applications (English)

1 reference

2 August 2017

Benjamin RJ

1

1 reference

2 August 2017

publication date

1 October 2001

1 reference

2 August 2017

published in

Seminars in Hematology

1 reference

2 August 2017

volume

38

1 reference

2 August 2017

issue

4 Suppl 9

1 reference

2 August 2017

page(s)

11-16

1 reference

Human parvovirus B19 infection in hemophiliacs first infused with two high‐purity, virally attenuated factor Vlll concentrates

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

The transfusion-associated transmission of parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

Duration of viremia in hepatitis A virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

PCR testing of plasma pools: from concept to reality

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

Food and Drug Administration conference on the feasibility of genetic technology to close the HIV window in donor screening

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

Direct HIV testing in blood donations: variation of the yield with detection threshold and pool size

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

Symptomatic parvovirus B19 infection and heat-treated factor IX concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

Should measures be taken to reduce the risk of human parvovirus (B19) infection by transfusion of blood components and clotting factor concentrates?

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

Redefining the HIV-infectious window period in the chimpanzee model: evidence to suggest that viral nucleic acid testing can prevent blood-borne transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

Detection of hepatitis A virus in a factor VIII preparation by antigen capture/PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufacture

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

Transfusion virology: progress and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

NAT of the United States and Canadian blood supply

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

Enzymatic amplification of hepatitis B virus DNA in serum compared with infectivity testing in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

Transmission of human parvovirus B19 by coagulation factor concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990132-5

7 January 2021

10.1016/S0037-1963(01)90132-5

Identifiers

DOI

1 reference

2 August 2017

1 reference